Ye L. Yang

399 Wanyuan Road
Shanghai, 201102, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 79 publications

Correction: CHEK1 and circCHEK1_246aa evoke chromosomal instability and induce bone lesion formation in multiple myeloma.

Correction: CHEK1 and circCHEK1_246aa evoke chromosomal instability and induce bone lesion formation in multiple myeloma.

Journal: Molecular cancer
Published: July 17, 2026

A polymer that reinforces luminal barrier function and attenuates inflammation in murine colitis.

A polymer that reinforces luminal barrier function and attenuates inflammation in murine colitis.

Journal: Research square
Published: June 29, 2026

Dexamethasone activates anti-tumor immunity in multiple myeloma by dismantling the GR-PPP1CB complex to restore STING/IRF3 signaling.

Dexamethasone activates anti-tumor immunity in multiple myeloma by dismantling the GR-PPP1CB complex to restore STING/IRF3 signaling.

Journal: Journal for immunotherapy of cancer
Published: June 08, 2026

Epstein-Barr virus-positive nodal T/NK-cell lymphoma presenting with hemophagocytic lymphohistiocytosis: a case report and literature review

Epstein-Barr virus-positive nodal T/NK-cell lymphoma presenting with hemophagocytic lymphohistiocytosis: a case report and literature review

Journal: Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi
Published: May 20, 2026

Engineered exosomes deliver structurally optimized toad BAX to reactivate mitochondrial apoptosis in colorectal cancer.

Engineered exosomes deliver structurally optimized toad BAX to reactivate mitochondrial apoptosis in colorectal cancer.

Journal: Frontiers in oncology
Published: May 15, 2026

Discovery of CN-3 as a Next-Generation RET Inhibitor Potently Overcoming Multiple Mutations.

Discovery of CN-3 as a Next-Generation RET Inhibitor Potently Overcoming Multiple Mutations.

Journal: Journal of medicinal chemistry
Published: May 02, 2026

Targeting AVEN Liquid-Liquid Phase Separation in Colorectal Cancer: Insights From a Raddeanin A-Based Chemical Probe.

Targeting AVEN Liquid-Liquid Phase Separation in Colorectal Cancer: Insights From a Raddeanin A-Based Chemical Probe.

Journal: Basic & clinical pharmacology & toxicology
Published: March 31, 2026

MAGEC2 promotes tumorigenesis in multiple myeloma through USP16-mediated deubiquitination and stabilization of c-Myc.

MAGEC2 promotes tumorigenesis in multiple myeloma through USP16-mediated deubiquitination and stabilization of c-Myc.

Journal: Experimental hematology & oncology
Published: February 13, 2026

DEAF1 confers resistance to adriamycin-induced apoptosis and pyroptosis in multiple myeloma.

DEAF1 confers resistance to adriamycin-induced apoptosis and pyroptosis in multiple myeloma.

Journal: Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy
Published: October 22, 2025

The Effectiveness of Huangkui Lianchang Decoction Enema Solution Compared with Mesalazine Enema for Mild-to-Moderate Active Distal Ulcerative Colitis: Study Protocol of a Multicenter, Prospective, Randomized Controlled Trial.

The Effectiveness of Huangkui Lianchang Decoction Enema Solution Compared with Mesalazine Enema for Mild-to-Moderate Active Distal Ulcerative Colitis: Study Protocol of a Multicenter, Prospective, Randomized Controlled Trial.

Journal: Journal of pain research
Published: October 13, 2025

FOXO3 upregulates and activates GSDME to trigger myeloma cell pyroptosis.

FOXO3 upregulates and activates GSDME to trigger myeloma cell pyroptosis.

Journal: International journal of biological sciences
Published: September 06, 2025

Oral colon-targeted paeonol emulsion for ameliorating ulcerative colitis based on charge adsorption.

Oral colon-targeted paeonol emulsion for ameliorating ulcerative colitis based on charge adsorption.

Journal: Drug delivery and translational research
Published: July 07, 2025
Showing 1-12 of 79

Last Updated: 09/26/2026